A Study of the Clinicopathological Effects of Chemotherapy for Human Esophageal Carcinoma

  • M. Iwatsuka
  • M. Yoshida
Conference paper

Abstract

The prognosis of esophageal carcinoma is not good in spite of technical advances in both surgery and radiation therapy [1, 2]. Our total resections of epidermoid carcinoma of the esophagus consist of 201 cases in the past 10 years, though the survival rate, among 102 cases after 5 years, is only 12%. Ninety percent of the patients who were admitted to us were in the advanced stages of the disease, so this is one of the reasons why esophageal carcinoma has such a poor prognosis, compared with other carcinomas of the digestive organs.

Keywords

Depression Platinum Bleomycin CDDP Vindesine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pearson JG (1971) The value of radiotherapy of the management of squamous esophageal cancer. Br J Surg 58:794–804PubMedCrossRefGoogle Scholar
  2. 2.
    Nakayama K, Kinoshita Y (1974) Surgical treatment combined with preoperative concentrated irradiation. JAMA 222:178–181CrossRefGoogle Scholar
  3. 3.
    Davis S, Shanmwgathasa M, Kessler W (1980) Cis-Dichlorodiamineplatinum(II) in the treatment of esophageal carcinoma. Cancer Treat Rep 64:709–711PubMedGoogle Scholar
  4. 4.
    Kelsen DP, Ahuja R, Hopfan S, Bains MS, Kosloff C, Martini N, McCormack P, Golbey B (1981) Combined modality therapy of esophageal carcinoma. Cancer 48:31–37PubMedCrossRefGoogle Scholar
  5. 5.
    Kelsen DP, Bains M, Chapman R, Golbey R (1981) Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma. Cancer Treat Rep 65:781–785PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • M. Iwatsuka
    • 1
  • M. Yoshida
    • 1
  1. 1.Tokyo Metropolitan Komagome HospitalTokyoJapan

Personalised recommendations